Autoimmune Diseases  >>  Copaxone 3TW (glatiramer acetate three times a week)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Copaxone 3TW (glatiramer acetate three times a week) / Teva
NCT02308670: Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis

Completed
N/A
150
US
University at Buffalo, Teva Pharmaceuticals USA
Multiple Sclerosis
10/16
10/16

Download Options